Charles Schwab
AHCO icon

Charles Schwab’s AdaptHealth AHCO Stock Holding History

Charles Schwab’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Sell
1,811,646
-271,283
-13% -$3.03M ﹤0.01% 1859
2026
Q1 		$24.8M Sell
2,082,929
-149,858
-7% -$1.53M ﹤0.01% 1614
2025
Q4 		$22.2M Buy
2,232,787
+326,820
+17% +$3.12M ﹤0.01% 1683
2025
Q3 		$17.1M Buy
1,905,967
+343,659
+22% +$3.18M ﹤0.01% 1839
2025
Q2 		$14.7M Buy
1,562,308
+260,656
+20% +$2.3M ﹤0.01% 1828
2025
Q1 		$14.1M Buy
1,301,652
+163,272
+14% +$1.64M ﹤0.01% 1800
2024
Q4 		$10.8M Sell
1,138,380
-91,984
-7% -$931K ﹤0.01% 1982
2024
Q3 		$13.8M Buy
1,230,364
+81,624
+7% +$867K ﹤0.01% 1886
2024
Q2 		$11.5M Sell
1,148,740
-96,026
-8% -$976K ﹤0.01% 1974
2024
Q1 		$14.3M Buy
1,244,766
+203,819
+20% +$1.73M ﹤0.01% 1802
2023
Q4 		$7.59M Buy
1,040,947
+183,135
+21% +$1.44M ﹤0.01% 2133
2023
Q3 		$7.81M Buy
857,812
+170,923
+25% +$2.05M ﹤0.01% 2049
2023
Q2 		$8.36M Buy
686,889
+89,545
+15% +$998K ﹤0.01% 1989
2023
Q1 		$7.42M Buy
597,344
+31,341
+6% +$577K ﹤0.01% 2013
2022
Q4 		$10.9M Buy
566,003
+15,684
+3% +$332K ﹤0.01% 1813
2022
Q3 		$10.3M Sell
550,319
-86,748
-14% -$1.78M ﹤0.01% 1814
2022
Q2 		$11.5M Sell
637,067
-6,831
-1% -$111K ﹤0.01% 1767
2022
Q1 		$10.3M Buy
643,898
+14,527
+2% +$261K ﹤0.01% 1941
2021
Q4 		$15.4M Buy
629,371
+17,728
+3% +$416K ﹤0.01% 1763
2021
Q3 		$14.2M Sell
611,643
-13,308
-2% -$322K ﹤0.01% 1812
2021
Q2 		$17.1M Buy
624,951
+112,061
+22% +$3.2M 0.01% 1698
2021
Q1 		$18.9M Buy
512,890
+264,507
+106% +$9.34M 0.01% 1574
2020
Q4 		$9.33M Buy
248,383
+26,034
+12% +$805K ﹤0.01% 1907
2020
Q3 		$4.85M Buy
222,349
+178,197
+404% +$3.74M ﹤0.01% 2076
2020
Q2 		$711K Buy
+44,152
New +$738K ﹤0.01% 2722

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab's AHCO Position: Q2 2026 in Review

Charles Schwab reduced its AdaptHealth (AHCO) stake by 13% in Q2 2026, selling an estimated $3.03M and leaving 1,811,646 shares worth $18.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Charles Schwab first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $24.8M in Q1 2026. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Charles Schwab held 1,811,646 shares of AdaptHealth worth $18.9M as of Q2 2026.
  • Charles Schwab sold 271,283 AdaptHealth shares in Q2 2026, an estimated $3.03M.
  • AdaptHealth made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1859 holding.
  • Charles Schwab first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • Charles Schwab's AdaptHealth position peaked at $24.8M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.